CIBC Bancorp USA’s Cytosorbents CTSO Stock Holding History
Bought
Maintained
Sold
Other funds holding CTSO
CM
CIBC Bancorp USA's CTSO Position: Q3 2026 in Review
CIBC Bancorp USA sold out of Cytosorbents (CTSO) in Q3 2026, closing a stake of 8,632 shares — an estimated $64.6K sold.
CIBC Bancorp USA first reported a position in CTSO in Q1 2026 and held it in 2 quarters. The position peaked at $97.8K in Q1 2026. 28 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.
- CIBC Bancorp USA reported no remaining Cytosorbents position as of Q3 2026 after selling out during the quarter.
- CIBC Bancorp USA sold 8,632 Cytosorbents shares in Q3 2026, an estimated $64.6K.
- CIBC Bancorp USA first reported a position in Cytosorbents in Q1 2026 and held it in 2 quarters.
- CIBC Bancorp USA's Cytosorbents position peaked at $97.8K in Q1 2026.
- 28 funds tracked by Wall St. Rank held Cytosorbents as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.